Sachdev Amit's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Nov 16, 2021
- Accession no.
- 0001209191-21-064740
- Filed
- Nov 16, 2021
- Trade date
- Nov 15, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $9.55K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachdev AmitCIK 0001406338 | Officer (EVP, Chief Patient Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common Stock | SSaleDisposed | −21 | $186.78 | −$3,922.38 | 31,958 | Direct | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −30 | $187.48 | −$5,624.4 | 31,928 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.